Anthem announced plans to rebrand as Elevance Health back in March, but one component still needed to be finalized: shareholder approval. The insurer received that approval this week, as shareholders gave the green light to the change at its annual mee…
The Department of Health and Human Services is announcing a funding opportunity of nearly $15 million for a three-year federal grant to establish a Substance Abuse and Mental Health Services Administration (SAMHSA) program meant to strengthen behaviora…
Under emergency use authorization, the U.S. Food and Drug Administration has expanded eligibility for the Pfizer-BioNTech COVID-19 booster vaccine to children 5 to 11 years old. People in that age group are now cleared for a single booster dose of the …
Employers and health insurers paid hospitals about 224% above what Medicare would have paid in 2020, according to a new RAND report comparing private insurer payments to Medicare rates.
In a partnership with Solera Health, BlueCross BlueShield of South Carolina is expanding its personalized health and wellness program to include mental and musculoskeletal health offerings.
Solera Health is an independent company that built a customiz…
Dartmouth Health and GraniteOne Health, both based in New Hampshire, are ditching their plans to merge into a single entity after objections from the state’s attorney general, who said the consolidation would result in higher healthcare prices.
After an extensive national search, Intermountain Healthcare has selected Tiffany Capeles, a nationally recognized diversity leader, as the health system’s first chief equity officer, the system has announced.
There’s been a nursing shortage in the U.S. for years, but the COVID-19 pandemic has made the situation even more dire. Nurses are retiring, leaving for new roles or abandoning the profession altogether, and there aren’t enough trainees in the academic…
Drug manufacturer Pfizer has entered into a definitive agreement to acquire Biohaven Pharmaceuticals, a maker of migraine treatments, for $11.6 billion, the former said this week.
Pfizer will also make payments at closing to settle Biohaven’s third par…